T. Toyoda et al., ATTENUATION OF ISCHEMIA-REPERFUSION INJURY IN THE RAT NEOCORTEX BY THE HYDROXYL RADICAL SCAVENGER NICARAVEN, Neurosurgery, 40(2), 1997, pp. 372-377
OBJECTIVE: Oxygen free radicals are considered important contributors
to cerebral ischemia-reperfusion injury. The purpose of this study was
to examine the effects of the hydroxyl radical scavenger, (+/-)-N,N'-
propylenedinicotinamide (nicaraven), on cerebral injury after focal is
chemia-reperfusion. METHODS: A total of 58 male Sprague-Dawley rats wa
s subjected to transient focal ischemia by occluding both carotid arte
ries and one middle cerebral artery for 3 hours. Animals received cont
inuous infusions of doses of 20 mg/kg per hour or 60 mg/kg per hour of
nicaraven beginning either 10 minutes before (pretreatment) or immedi
ately after (posttreatment) ischemia. Infarction volumes were evaluate
d by staining coronal brain sections with 2% 2,3,5-triphenyltetrazoliu
m chloride (n = 40). In other animals (n = 18), brain edema was evalua
ted 1 hour after ischemia. RESULTS: A dose of 20 mg/kg per hour of nic
araven elicited small reductions in infarction volume (14.7 and 12.3%
for the pre- and posttreatment groups, respectively). Treatment with a
dose of 60 mg/kg per hour of nicaraven provided significant reduction
s in the volume of infarction (18.6% [P < 0.05] and 20.9% [P < 0.01] r
eductions for the pre- and posttreatment groups, respectively). The re
ductions in infarction size did not differ significantly between the p
re- and posttreatment groups receiving a dose of 60 mg/kg per hour of
nicaraven. Posttreatment with either dose of nicaraven significantly r
educed brain edema. CONCLUSIONS: This study demonstrates the neuroprot
ective effects of a hydroxyl radical scavenger when administered syste
mically during the reperfusion phase after transient focal ischemia. T
he results provide, to our knowledge, the first evidence that nicarave
n is effective against ischemia-reperfusion injury in the brain and de
monstrate that oxygen free radicals generated during reperfusion are i
mportant triggers of ischemic brain damage. Furthermore, the findings
suggest that nicaraven may be a useful agent in limiting brain injury
after ischemic stroke.